Understanding emotional dysregulation in psychiatric patients
Retrospective Study of the Acceptability and Effectiveness of a Dialectical Behavioral Therapy Group in Patients Suffering From Emotional Dysregulation (Borderline Personality Disorder, Bipolar Disorder and Adult ADHD)
This study is trying to learn more about how emotional struggles affect adults with psychiatric disorders who have been in dialectical behavioral therapy.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 100 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University Hospital, Strasbourg, France Academic / other |
| Locations | 1 site (Strasbourg) |
| Trial ID | NCT06616337 on ClinicalTrials.gov |
What this trial studies
This observational study focuses on emotional dysregulation (ED), a common syndrome in various psychiatric disorders such as schizophrenia, bipolar disorder, borderline personality disorder, and ADHD. The research is conducted at the University Hospitals of Strasbourg, where groups have been utilizing dialectical behavioral therapy to address ED for nearly three years. The study aims to gather data from participants who have engaged in this therapy to better understand the impact of ED on their psychological well-being and quality of life. Participants must be adults who consent to the reuse of their data for scientific purposes.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and older who have participated in the GREMO group therapy sessions.
Not a fit: Patients who oppose the reuse of their personal data for research purposes will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance therapeutic approaches for managing emotional dysregulation in patients with psychiatric disorders.
How similar studies have performed: While dialectical behavioral therapy has shown effectiveness in treating emotional dysregulation, this specific observational approach is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Major subject (≥18 years old) * Having participated in the first session of a GREMO group, which is a behavioral and dialectical therapy protocol from January 1, 2018 to December 31, 2023, * Subject not opposing the reuse of their data for scientific research purposes. Exclusion Criteria: * Subject having expressed their opposition to the reuse of their personal data for scientific research purposes.
Where this trial is running
Strasbourg
- Service de Psychiatrie 2 - CHU de Strasbourg - France — Strasbourg, France (Recruiting)
Study contacts
- Study coordinator: Sébastien WEIBEL, MD
- Email: sebastien.weibel@chru-strasbourg.fr
- Phone: 33 3 88 11 51 57
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.